» Authors » Juan E Gallo

Juan E Gallo

Explore the profile of Juan E Gallo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 341
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Perisset S, Potilinski M, Gallo J
Int J Mol Sci . 2023 Sep; 24(18). PMID: 37762249
Important advances in diabetic retinopathy (DR) research and management have occurred in the last few years. Neurodegenerative changes before the onset of microvascular alterations have been well established. So, new...
2.
Torres I, Gallo J, Gomez O, Rua-Giraldo A, McEwen J, Garcia A
Biomedica . 2022 Dec; 42(4):697-706. PMID: 36511671
Introduction: Fluconazole is the most used antifungal drug for prevention and treatment of Cryptococcus spp. infections, the etiological agent of cryptococcosis. Resistance to fluconazole among Cryptococcus neoformans isolates can lead...
3.
Axfors C, Janiaud P, Schmitt A, Vant Hooft J, Smith E, Haber N, et al.
BMC Infect Dis . 2021 Nov; 21(1):1170. PMID: 34800996
Background: Convalescent plasma has been widely used to treat COVID-19 and is under investigation in numerous randomized clinical trials, but results are publicly available only for a small number of...
4.
Bazan N, Reid M, Cruz Flores V, Gallo J, Lewis W, Belayev L
Cancer Metastasis Rev . 2021 Sep; 40(3):643-647. PMID: 34519960
Glioblastoma multiforme (GBM) is the most invasive type of glial tumor with poor overall survival, despite advances in surgical resection, chemotherapy, and radiation. One of the main challenges in treating...
5.
Castaneda S, Patino L, Munoz M, Ballesteros N, Guerrero-Araya E, Paredes-Sabja D, et al.
Vaccines (Basel) . 2021 Aug; 9(8). PMID: 34451962
Current efforts to understand the epidemiology, transmission dynamics and emergence of novel SARS-CoV-2 variants worldwide has enabled the scientific community to generate critical information aimed at implementing disease surveillance and...
6.
Gallo J, Torres I, Gomez O, Rishishwar L, Vannberg F, Jordan I, et al.
J Fungi (Basel) . 2021 Aug; 7(7). PMID: 34356923
Histoplasmosis is a systemic fungal disease caused by the pathogen spp. that results in significant morbidity and mortality in persons with HIV/AIDS and can also affect immunocompetent individuals. Although some...
7.
Potilinski M, Tate P, Lorenc V, Gallo J
Neuropharmacology . 2021 Mar; 188:108513. PMID: 33662390
The prevalence of age-related macular degeneration (AMD) has increased in the last years. Although anti-VEGF agents have improved the prognosis of exudative AMD, dry AMD has still devastating effects on...
8.
Salica J, Potilinski C, Querci M, Navarro I, Rivero J, Daponte P, et al.
Clin Ophthalmol . 2021 Feb; 15:261-278. PMID: 33519188
The COVID-19 pandemic has forced all nations to take an active role in infection control incorporating recommendations and measures to control viral dissemination. The epidemiological impact is very diverse and...
9.
Gallo J, Ochoa J, Warren H, Misas E, Correa M, Gallo-Villegas J, et al.
Int J Cardiol Hypertens . 2020 Dec; 7:100050. PMID: 33330845
Background: The band 9p21.3 contains an established genomic risk zone for cardiovascular disease (CVD). Since the initial 2007 Wellcome Trust Case Control Consortium study (WTCCC), the increased CVD risk associated...
10.
Misas E, Gomez O, Botero V, Munoz J, Teixeira M, Gallo J, et al.
Front Microbiol . 2020 Aug; 11:1751. PMID: 32849380
The mitochondrial genome of the reference isolate Pb18 was first sequenced and described by Cardoso et al. (2007), as a circular genome with a size of 71.3 kb and containing...